187 related articles for article (PubMed ID: 32143894)
1. Prevention and therapy of viral infections in patients with solid organ transplantation.
Silva JT; Fernández-Ruiz M; Aguado JM
Enferm Infecc Microbiol Clin (Engl Ed); 2021 Feb; 39(2):87-97. PubMed ID: 32143894
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis.
Humar A
Transplantation; 2006 Jul; 82(2 Suppl):S9-S14. PubMed ID: 16858271
[TBL] [Abstract][Full Text] [Related]
3. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
Carratalà J; Montejo M; Pérez-Romero P
Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
[TBL] [Abstract][Full Text] [Related]
4. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
5. A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients.
Moghadamnia M; Eshaghi H; Alimadadi H; Dashti-Khavidaki S
Front Pediatr; 2023; 11():1252495. PubMed ID: 37732007
[TBL] [Abstract][Full Text] [Related]
6. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
7. [Opportunistic infections by human herpes viruses].
Floß N; Dolff S
Internist (Berl); 2019 Jul; 60(7):678-683. PubMed ID: 31089769
[TBL] [Abstract][Full Text] [Related]
8. Herpes Virus Infection in Lung Transplantation: Diagnosis, Treatment and Prevention Strategies.
Patrucco F; Curtoni A; Sidoti F; Zanotto E; Bondi A; Albera C; Boffini M; Cavallo R; Costa C; Solidoro P
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140567
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial prophylaxis in solid-organ transplantation.
Bassetti M; Righi E; Bassetti D
Expert Rev Anti Infect Ther; 2004 Oct; 2(5):761-9. PubMed ID: 15482238
[TBL] [Abstract][Full Text] [Related]
10. How I prevent viral reactivation in high-risk patients.
Dadwal SS; Papanicolaou GA; Boeckh M
Blood; 2023 Apr; 141(17):2062-2074. PubMed ID: 36493341
[TBL] [Abstract][Full Text] [Related]
11. Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant.
Bassil N; Rostaing L; Mengelle C; Kallab S; Esposito L; Guitard J; Cardeau-Desangles I; Weclawiak H; Izopet J; Kamar N
Exp Clin Transplant; 2014 Jun; 12(3):212-9. PubMed ID: 24907721
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcome of concurrent and sequential multiviral cytomegalovirus, Epstein-Barr virus, BK virus, adenovirus and other viral reactivations in transplantation.
Sim BZ; Yong KY; Slavin MA; Yong MK
Curr Opin Infect Dis; 2022 Dec; 35(6):536-544. PubMed ID: 36255049
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
[TBL] [Abstract][Full Text] [Related]
14. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections.
Razonable RR; Paya CV
Herpes; 2003 Dec; 10(3):60-5. PubMed ID: 14759337
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
16. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: A systematic review of the literature.
Anderson-Smits C; Baker ER; Hirji I
Transpl Infect Dis; 2020 Dec; 22(6):e13396. PubMed ID: 32603496
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature.
Stubbins RJ; Alami Laroussi N; Peters AC; Urschel S; Dicke F; Lai RL; Zhu J; Mabilangan C; Preiksaitis JK
Transpl Infect Dis; 2019 Feb; 21(1):e13010. PubMed ID: 30298678
[TBL] [Abstract][Full Text] [Related]
18. Significance of human herpesviruses to transplant recipients.
Yoshikawa T
Curr Opin Infect Dis; 2003 Dec; 16(6):601-6. PubMed ID: 14624112
[TBL] [Abstract][Full Text] [Related]
19. A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score.
San-Juan R; Fernández-Ruiz M; Ruiz-Ruigómez M; López-Medrano F; Ruiz-Merlo T; Andrés A; Loinaz C; Len O; Azancot MA; Montejo M; Rodriguez-Alvarez R; Fortún J; Escudero-Sánchez R; Giménez E; Lora D; Albert E; Navarro D; Aguado JM;
J Infect Dis; 2020 Jul; 222(3):479-487. PubMed ID: 32112085
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Detection of Beta and Gamma Human Herpesviruses by Multiplex qPCR Reveals Simple Infection and Coinfection Episodes Increasing Risk for Graft Rejection in Solid Organ Transplantation.
Sánchez-Ponce Y; Varela-Fascinetto G; Romo-Vázquez JC; López-Martínez B; Sánchez-Huerta JL; Parra-Ortega I; Fuentes-Pananá EM; Morales-Sánchez A
Viruses; 2018 Dec; 10(12):. PubMed ID: 30572622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
